Primary Article

Cinoxacin Therapy for Urinary Tract Infections Therapeutic Safety and Efficacy

Authors: C. E. COX MD, J. R. SIMMONS BBA

Abstract

ABSTRACTWe gave cinoxacin to 125 patients with initial and recurrent urinary tract infections to investigate the safety and efficacy of this new antimicrobial agent. Patients ranging in age from 18 to 92 were treated with 500 mg twice daily for nine days. Analysis showed a satisfactory symptomatic response rate of 96% and a bacteriologic cure rate of 92%, with mild side effects observed in 6% of the participants.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References